 OncLive |
Targeting CD20: Rituximab’s Success Fuels Interest in New Agents – OncLive
OncLive The first anticancer antibody on the market was rituximab, which targets the membrane protein CD20 and, since its approval in the late 1990s, it has revolutionized the treatment of B-cell malignancies, with huge improvements in survival rates. However … |
Biogen Idec Total Revenues Increased 10% to $1.4 Billion in First Quarter 2013MarketWatch (press release)On April 4, 2013, Biogen Idec announced results from the daclizumab high-yield process (DAC HYP) SELECT clinical trial were published in an on-line…
 Bioscience Technology |
MCCIR scientists use video imaging to investigate effectiveness of rituximab …
News-Medical.net Professor Daniel Davis and his team used high quality video imaging to investigate why the drug rituximab is so effective at killing cancerous B cells. It is widely used in the treatment of B cell malignancies, such as lymphoma and leukaemia – as well … ‘Achilles’ heel’ of cancer cells discovery by Manchester scientists could …Mancunian Matters |
|
Video reveals cancer cells’ Achilles’ heel
HealthCanal.com Professor Daniel Davis and his team used high quality video imaging to investigate why the drug rituximab is so effective at killing cancerous B cells. It is widely used in the treatment of B cell malignancies, such as lymphoma and leukaemia – as well … |
|
Antibodies to perform Saturday at family-friendly ‘Music at the Shoals’ event
Spartanburg Herald Journal The Spartanburg community is invited to the family-friendly “Music at the Shoals” concert, featuring the local band the Antibodies, at 5:30 p.m. Saturday at the Cole Family Amphitheatre at Wofford College’s Goodall Environmental Studies Center at Glendale. |
|
Fighting bacteria with a new genre of antibodies
Eureka! Science News Their inspiration was the antibodies that the immune system produces when microbes invade the body. Those antibodies patrol the body for microbes and bind to their surfaces, triggering a chain of events in which the body’s immune system attacks and … |
Fighting bacteria with a new genre of antibodies – EurekAlert!EurekAlert (press release)In an advance toward coping with bacteria that shrug off existing antibiotics and sterilization methods, scientists are reporting development of a new family of sel…
|
Video reveals cancer cells’ Achilles’ heel – EurekAlert!
EurekAlert (press release) Professor Daniel Davis and his team used high quality video imaging to investigate why the drug rituximab is so effective at killing cancerous B cells. It is widely used in the treatment of B cell malignancies, such as lymphoma and leukaemia – as well … |
Smoking Raises Risk of Lung Disease in RA – MedPage TodayMedPage TodayThese changes are likely to reflect the earlier use of older immunosuppressive agents such as cyclophosphamide and the wider use of newer agents such as mycophenolate mofetil (CellCe…
MDS And AML Patients May Achieve Similar Outcomes Post Transplant With …The MDS BeaconIn addition, 95 percent of patients received fludarabine (Fludara). For the prevention of GVHD, 79 percent of patients received cyclosporine (Sandimmune) plus mycop…